Injections of antibodies might prevent mild COVID-19 from becoming severe, but the treatments are expensive and difficult to make.
No comments yet. Be the first to comment!
Users invited can see your content
- The Economist (2020)
- FierceBiotech (2020)
- TechCrunch (2020)
(2020)
- The Conversation (2020)
- Forbes (2020)
- CNBC (2020)
- TheHill (2020)
(2022)
- STAT (2021)
- Gizmodo (2021)
- STAT (2020)
- BBC News (2020)
- Science (2020)
- Science | AAAS (2020)
Related chunks with this resource
No comments yet. Be the first to comment!